Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-05
1998-02-03
Lambkin, Deborah
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514424, A61K 3140
Patent
active
057145105
ABSTRACT:
A composition and method for ameliorating a cellular dysfunction of a tissue such as the cosmetic treatment of hair loss and stimulation of hair growth is disclosed. The method comprises administering substituted or unsubstituted 2,2,5,5-tetramethyl-1-pyrrolidinyloxyl (PROXYL) to the affected tissue.
REFERENCES:
patent: 2409754 (1946-10-01), Henze
patent: 2986573 (1961-05-01), Topliss
patent: 3257390 (1966-06-01), Patchett
patent: 3461461 (1969-08-01), Anthony et al.
patent: 3527864 (1970-09-01), MacMillen et al.
patent: 3551554 (1970-12-01), Herschler
patent: 3896238 (1975-07-01), Smith
patent: 4139619 (1979-02-01), Chidsey, III
patent: 4189039 (1980-02-01), Soldati
patent: 4254145 (1981-03-01), Birnbaum
patent: 4344941 (1982-08-01), Wiechert
patent: 4347245 (1982-08-01), Shapiro
patent: 4367227 (1983-01-01), Bingham
patent: 4444762 (1984-04-01), Rajadhyaksha
patent: 4456600 (1984-06-01), Wiechert
patent: 4596812 (1986-06-01), Chidsey, III
patent: 4866067 (1989-09-01), Di Schiena
patent: 5120831 (1992-06-01), Pickart
patent: 5177061 (1993-01-01), Pickart
patent: 5214032 (1993-05-01), Pickart
patent: 5252559 (1993-10-01), Kronholm
patent: 5256678 (1993-10-01), Nakaguchi
Fiedler, Dermatologica, vol. 175, suppl. 2, pp. 29-35 (1987).
Fox et al., Annals of the New York Academy of Sciences, vol. 411, pp. 14-19 (1983).
Goffman et al. International Journal of Radiation, Oncology, Biology and Physics, vol. 22, pp. 803-806 (Nov. 4, 1992).
Headington, Current Therapeutic Research, vol. 36, pp. 1098-1105 (1984).
Hearse et al., Circulation Research, vol. 60, pp. 375-383 (1987).
Herschler, Chemical Abstracts, vol. 78, pp. 115239 (1973).
Ingarro et al., Biochemica et. Biophysica Acta, vol. 631, pp. 221-231 (1980).
J., Soc. Cosmetology Chem., (Italy) vol. 33, pp. 95-96 (Mar./Apr. 1982).
Journal of American Medical Association, vol. 260, No. 20 (1988).
Karlsson et al., Journal of Cyclic Nucleotide and Protein Res., vol. 10, No. 4, pp. 309-315 (1985).
Kvedar, Journal of American Academic Dermatology, vol. 12, pp. 215-225 (1985).
Longevity, vol. 2, No. 3, p. 26 (Jan. 1988).
Lucky, Archives of Dermatology, vol. 121, pp. 57-62 (1985).
Messina, Current Therapeutic Research, vol. 34, pp. 319-324 (1983).
Messina, Current Therapeutic Research, vol. 38, pp. 269-282 (1985).
Mitchell et al., IBC USA Conference, South Natick, MA (Jun. 27, 1991).
Voorhees (Ed.), Dermatologica, vol. 175, suppl. 2, pp. 1-56 (1987).
Watanabe et al., Archives of Dermatological Research, vol. 278, pp. 470-473 (1986).
Weissmann, Archives of Dermatology, vol. 121, pp. 57-62 (1985).
Yoshioka et al. Archives of Dermatological Research, vol. 278, pp. 177-183 (1986).
Proctor, Archives of Dermatology, p. 1146 (Aug. 1989).
Gelvan et al., Proc. of National Academy of Science, USA, vol. 88, pp. 4680-4684 (1991).
Samuni et al., Biochemistry, vol. 30, pp. 555-561 (1991).
Mittal et al., Proc. of National Academy of Science, USA, vol. 74, No. 10, pp. 4360-4364 (1977).
Palmer et al., Nature, vol. 327, pp. 524-526 (Jun. 11, 1987).
Parrett et al., Journal of Pharmacology, vol. 91, pp. 49-59 (1987).
Physician's Desk Reference, pp. 883, 977-978, 1782-1785, 1961 (1983).
Proctor et al., Physiological Chemistry and Physics in Medical NMR, vol. 16, pp. 175-195 (1984).
Ross, U.S. Department of Commerce, National Bureau of Standards, Publication NSRDS-NBS59 (Jan. 1977).
Sekura, Advances of Biology and Skin, vol. XII, pp. 257-269, (1972).
Shapiro et al., Journal of Clinical Endocrinology and Metabolism, vol. 51, pp. 429-430 (1980).
Stewart, International Journal of Dermatology, vol. 17, pp. 167-179 (1978).
Thompson, Federal Drug Administration Consumer, pp. 10 and 12 (Mar. 10, 1981).
Tiffany-Castiglion, Biochemical Pharmacology, vol. 31, No. 2, pp. 181-188 (1982).
Torre (Ed.), Annals of the New York Academy of Sciences, vol. 411, Table of Contents (1983).
Vermorken, Acta Dermatovener (Stockholm), vol. 63, pp. 268-269 (1982).
Anderson, Chemical Abstracts, vol. 90, pp. 311K (1979).
Ando et al., Chemical Abstracts, 93:79872n (1980).
Bazzano et al., Journal of American Academy of Dermatology, vol. 15, pp. 880-883 (1986).
Berry, Pharmacology of the Skin, vol. 1, pp. 121-137 (1987).
Cheng et al., Archives of Dermatological Research, vol. 278, pp. 470-473 (1986).
Cumming et al., Journal of American Medical Association, vol. 247, pp. 1295-1298 (1982).
Current Therapy, pp. 599-603 (1984).
Dahl, Men's Fitness, pp. 93-95 (Feb. 1989).
Dawber, Dermatologica, vol. 175, suppl. 2, pp. 23-28 (1987).
DeVillez, Archives of Dermatology, vol. 121, pp. 197-202, (1985).
Dermatologica, vol. 175, suppl. 2, pp. 1-56 (Oct. 1987).
Dostert et al., Xenobiotica, vol. 15, No. 10, pp. 799-803 (1985).
Ehman et al., Investigative Radiology, vol. 21, pp. 125-131 (1986).
Feelisch et al., Evr. Journal of Pharmacology, vol. 139, pp. 19-30 (1987).
Feelisch et al., Evr. Journal of Pharmacology, vol. 142, pp. 405-409 (1987).
Hahn et al, "Identification of Nitroxide Radioprotectors", CA 117:229205, (1992).
Lambkin Deborah
Lundeen Daniel N.
LandOfFree
Topical proxyl composition and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical proxyl composition and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical proxyl composition and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-662719